ArticleThe New England journal of medicine2016
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
163 papers cite itlatest 60 shown
this paperpooled ittrialcites it